In this episode Taschi explores the emerging burgeoning market for psychedelic drugs to address the current mental health crisis as a response to Covid-19 lockdown measures.
Drug companies took their positions in 2019 and key players are linked to social impact investing. In his 1930s novel Brave New World, Aldous Huxley described the use of a fictitious psychotropic drug for mass control of a subservient population. In 2021 it would seem it can also be profitable.